Methylphenidate and Proair respiclick drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Proair respiclick (albuterol sulfate). Common drug interactions include dizziness among females and neuralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Proair respiclick. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Proair respiclick?

Proair respiclick has active ingredients of albuterol sulfate. eHealthMe is studying from 2,468 Proair respiclick users. Check the latest studies of Proair respiclick.



On Jul, 16, 2026

13 people who take Methylphenidate and Proair respiclick together, and have interactions are studied.

Methylphenidate and Proair respiclick drug interactions.

What are the common drug interactions of Methylphenidate and Proair Respiclick, by gender? *:

female:

  1. Dizziness
  2. Ear infection
  3. Hypoacusis (loss of hearing)
  4. Inner ear disorder
  5. Lymphatic fistula (a leakage of lymphatic fluid from lymphatic vessel)
  6. Middle ear effusion (fluid in middle ear)
  7. Multiple allergies (allergy to multiple agents)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Pulmonary embolism (blockage of the main artery of the lung)

male:

  1. Neuralgia (pain in one or more nerves)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Empyema (collection of pus in a cavity in the body)
  4. Pericardial effusion (fluid around the heart)
  5. Postoperative wound infection
  6. Weight decreased
  7. Diarrhoea
  8. Injury
  9. Obesity (having too much body fat)
  10. Retinal tear

What are the common drug interactions of Methylphenidate and Proair Respiclick, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Loss of consciousness

30-39:

  1. Psoriasis (immune-mediated disease that affects the skin)

40-49:

  1. Sinusitis (inflammation of sinus)

50-59:

  1. Diarrhoea
  2. Obesity (having too much body fat)
  3. Type 2 diabetes mellitus
  4. Vomiting
  5. Weight decreased

60+:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Dizziness
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Middle ear effusion (fluid in middle ear)
  5. Multiple allergies (allergy to multiple agents)
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Productive cough
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Seasonal allergy (allergic condition due to certain season)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 53.85%
  2. Neuralgia (pain in one or more nerves): 4 people, 30.77%
  3. Immunodeficiency Common Variable: 3 people, 23.08%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
  6. Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 1 person, 7.69%
  7. Eosinophilic Esophagitis (Eosinophilic esophagitis (EoE) is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Proair respiclick?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylphenidate and Proair respiclick:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proair respiclick:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proair respiclick and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate and albuterol sulfate (the active ingredients of Methylphenidate and Proair respiclick, respectively), and Methylphenidate and Proair respiclick (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: